The Heroes With Hearing Loss program, sponsored by Hamilton CapTel®, introduces veterans with hearing loss to resources and solutions that best meet their individual and unique needs.
According to Department of Defense statistics, hearing loss is the number one war-related injury affecting veterans from the battlefields of Iraq and Afghanistan. An estimated 60 percent of veterans returning from Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) have some hearing damage, with 840,000 suffering from tinnitus and just over 700,000 suffering from hearing loss. More than 1.2 million veterans from every generation suffer from some form of hearing loss.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62613-heroes-with-hearing-loss-new-program-debuts-vfw-national-convention
SCI Total Fitness is an online program which offers those with spinal cord injuries a wheelchair exercise program. This disability exercise class is for those who want to get fit and lose weight. visit here for more information : scitotalfitness.com
Today, Easter Seals released the Spanish version of the online developmental screening, the Ages & Stages Questionnaires® (ASQ), making it one step closer to its goal of having all kids under five screened for developmental delays, autism and other disabilities, and allowing for every family to access the screening free of charge.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55359-easter-seals-week-of-the-young-child-free-online-developmental-screening
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
Recent unfounded statements surrounding the safety of wheelchair accessible vehicle conversions has caused industry organizations to rally in an effort to set the record straight. The National Mobility Equipment Dealers Association (NMEDA) and several of its manufacturing members announced today their position on the recent allegations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54214-braunability-disability-organizations-react-to-misleading-statements
The Arthritis Foundation is joining a global effort on Oct. 12, World Arthritis Day, to increase awareness of the many forms of arthritis and to call on individuals and policymakers to take action to reduce the burden of arthritis around the world.
Arthritis affects several hundred million people worldwide. In the United States, it’s the nation’s leading cause of disability, affecting one in five adults (50 million). The disease exacts a hefty financial toll, costing the U.S. economy $128 billion annually. As the staggering prevalence of arthritis continues to rise, the Arthritis Foundation is calling on the nation and individuals to “Move to Improve” to reduce the severe health and economic effects of this disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52066-ad-council-world-arthritis-day-move-to-improve-october-12
CVS Caremark and Children’s Hospital Boston will celebrate a mutually significant milestone at Fenway Park this evening. Just prior to the Boston Red Sox/Baltimore Orioles game, the two will recognize hitting the $1 million mark in funds donated to the Hospital by CVS Caremark for children with disabilities. The relationship that brought them to this point spans more than five years and focuses on a shared commitment to helping children with disabilities. Monies donated derive from the CVS Caremark Charitable Trust and the CVS Caremark All Kids Can Program and support the Hospital’s Cerebral Palsy Program and its Center for Communication Enhancement.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52103-cvs-caremark-reaches-1-million-in-donations-children-s-hospital-boston
Billie Jean King is joining the Arthritis Foundation, the Ad Council and the United States Tennis Association (USTA) to launch a new public service campaign to fight arthritis—the leading cause of disability in America. The ads, which debut at the US Open today, highlight the power of movement and activities, such as tennis, walking, biking and swimming, as weapons in the fight against osteoarthritis (OA). They will premiere on TV screens and PA announcements and in signage and collateral materials throughout the US Open in the Arthur Ashe Stadium.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51773-ad-council-fight-arthritis-pain
New data revealed that nearly 100 percent (99%) of 200 U.S. primary care physicians surveyed agree that heart disease and stroke are the number one cause of death and disability among type 2 diabetes patients; however, almost 40 percent (36%) of these physicians underestimate the number of patients who die from cardiovascular disease. Furthermore, while people with diabetes are two to four times more likely to have heart disease than people without diabetes, the survey, conducted by Harris Interactive and supported by Merck, found only one out of five (21%) patients (n=664) listed heart attack or heart failure as their biggest worry regarding diabetes complications, and even fewer patients (7%) listed stroke.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/merck/50638/
An international team of researchers led by Gerard D. Schellenberg, PhD, a member of the CurePSP Genetics Consortium and professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania, has identified three new genes that can increase the risk of people developing Progressive Supranuclear Palsy (PSP).
PSP is a rare neurodegenerative brain disease, similar to Parkinson’s disease, which causes severe disability by destroying parts of cells that allow the brain to function normally. While PSP has underlying biological similarities to Alzheimer’s disease, a disease which primarily affects memory, PSP impacts a person’s physical movement and bodily functions. PSP leads to progressive decline in patients — there is no known cause or cure.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/psp/49958/
